Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.
This study has been terminated.
(The reason for termination was lack of tolerability and efficacy of the combination treatment)
First Posted: November 25, 2010
Last Update Posted: May 9, 2017
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||April 23, 2015|
|Primary Completion Date:||January 30, 2014 (Final data collection date for primary outcome measure)|